Skip to main content

Peer Review reports

From: Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension

Original Submission
28 Aug 2021 Submitted Original manuscript
27 Sep 2021 Reviewed Reviewer Report
3 Oct 2021 Reviewed Reviewer Report
25 Oct 2021 Author responded Author comments - Jianqiang Peng
Resubmission - Version 2
25 Oct 2021 Submitted Manuscript version 2
20 Nov 2021 Author responded Author comments - Jianqiang Peng
Resubmission - Version 3
20 Nov 2021 Submitted Manuscript version 3
25 Nov 2021 Reviewed Reviewer Report
3 Dec 2021 Reviewed Reviewer Report
15 Jan 2022 Author responded Author comments - Jianqiang Peng
Resubmission - Version 4
15 Jan 2022 Submitted Manuscript version 4
26 Jan 2022 Author responded Author comments - Jianqiang Peng
Resubmission - Version 5
26 Jan 2022 Submitted Manuscript version 5
13 Feb 2022 Author responded Author comments - Jianqiang Peng
Resubmission - Version 6
13 Feb 2022 Submitted Manuscript version 6
27 Mar 2022 Author responded Author comments - Jianqiang Peng
Resubmission - Version 7
27 Mar 2022 Submitted Manuscript version 7
Publishing
4 Apr 2022 Editorially accepted
12 Apr 2022 Article published 10.1186/s12890-022-01939-7

You can find further information about peer review here.

Back to article page